Louisiana State Employees Retirement System’s TG Therapeutics TGTX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.18M	Sell	57,800 -2,500	-4%	-$102K	0.05%	369
2026 Q1	$2M	Sell	60,300 -2,000	-3%	-$59.6K	0.04%	551
2025 Q4	$1.86M	Sell	62,300 -100	-0.2%	-$3.27K	0.03%	581
2025 Q3	$2.25M	Sell	62,400 -1,000	-2%	-$32.9K	0.04%	467
2025 Q2	$2.28M	Buy	63,400 +500	+0.8%	+$18.6K	0.04%	439
2025 Q1	$2.48M	Sell	62,900 -1,600	-2%	-$53.8K	0.05%	358
2024 Q4	$1.94M	Hold	64,500	–	–	0.04%	533
2024 Q3	$1.51M	Buy	+64,500	New	+$1.41M	0.03%	725

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Louisiana State Employees Retirement System's TGTX Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its TG Therapeutics (TGTX) stake by 4.1% in Q2 2026, selling an estimated $102K and leaving 57,800 shares worth $3.18M. The position accounts for 0.05% of the portfolio, ranked #369.

Louisiana State Employees Retirement System first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Louisiana State Employees Retirement System held 57,800 shares of TG Therapeutics worth $3.18M as of Q2 2026.
Louisiana State Employees Retirement System sold 2,500 TG Therapeutics shares in Q2 2026, an estimated $102K.
TG Therapeutics made up 0.05% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #369 holding.
Louisiana State Employees Retirement System first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.